Chemistry of Longevity: Rapamycin's Secret Past and Potential for a Longer Life
September 22, 2016
The FDA approved drug rapamycin has been found to delay aging and increase lifespan in diverse laboratory organisms, including yeast, nematodes, fruit flies, and mice. Although the mechanisms by which rapamycin achieves these remarkable effects are still being elucidated, attention is now turning toward translational applications and studies aimed at determining whether these benefits can be obtained outside of the laboratory.
What You Will Learn
- Aging is a modifiable biological process; it can be accelerated and delayed through interventions
- Rapamcyin is a drug that has been shown to delay aging in evolutionarily diverse laboratory organisms
- Companion dogs offer an outstanding opportunity to begin translating work with rapamycin and other interventions that promote healthy aging from the lab to the clinic
- Rapamycin’s Secrets Unearthed - Article by Bethany Halford of c&en
- The Canadian Medical Expedition to Easter Island - A short video detailing the expedition
- Rapamycin’s Resurrection: A New Way to Target the Cancer Cell Cycle - Article from the Journal of the National Institute of Cancer
- Does a Real Anti-Aging Pill Already Exist - Article from Bloomberg Businessweek
- Dogs Test Drug Aimed at Humans’ Biggest Killer: Age - Article from The New York Times
- Dog Aging Project - Website to increase the healthy lifespan of pet dogs by targeting the aging process directly
- Kaeberlein Lab - focused on developing therapies for age-associated diseases by targeting the pathways that regulate aging
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.